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Alternative splicing of gene transcripts greatly expands the func-
tional capacity of the genome, and certain splice isoforms may indi-
cate specific disease states such as cancer. Splice junction microarrays
interrogate thousands of splice junctions, but data analysis is diffi-
cult and error prone because of the increased complexity compared to
differential gene expression analysis. We present Rank Change Detec-
tion (RCD) as a method to identify differential splicing events based
upon a straightforward probabilistic model comparing the over- or
underrepresentation of two or more competing isoforms. RCD has
advantages over commonly used methods because it is robust to false
positive errors due to nonlinear trends in microarray measurements.
Further, RCD does not depend on prior knowledge of splice isoforms,
yet it takes advantage of the inherent structure of mutually exclusive
junctions, and it is conceptually generalizable to other types of splic-
ing arrays or RNA-Seq. RCD specifically identifies the biologically
important cases when a splice junction becomes more or less preva-
lent compared to other mutually exclusive junctions. The example
data is from different cell lines of glioblastoma tumors assayed with
Agilent microarrays.
1. Introduction. Genomic DNA contains the sequential codes for con-
structing proteins that perform biochemical and structural tasks essential
for life. The DNA of a gene is first transcribed into a pre-messenger RNA
(pre-mRNA) transcript. The rate of transcription is referred to as gene ex-
pression and is a measure of the gene’s level of activity. The DNA fragment
encoding a particular gene does not get entirely converted into mRNA. A
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Fig. 1. Schematic of splicing process, incompatible junctions and junction probes. The
gene is shown at the top. The splicing process has two possibilities. First, remove exon
1b (Black) and intron 1. The fusion between exons 1a and 2 results in Junction 1. Sec-
ond, only remove intron 1 while retaining exon 1b. The fusion between exons 1b and 2
results in Junction 2. The retention of exon 1b is translated into an abnormal protein, and
higher fluorescence of the Junction 2 probe relative to the Junction 1 probe indicates this
abnormality.
gene is composed of sequence blocks called introns and exons. The introns
are removed or spliced out of the pre-mRNA sequence, whereas the exons are
retained to form the mature mRNA which is later translated into proteins.
However, some exons are selectively included in the mature mRNA so that
different splicing variants or isoforms result. The different splicing variants
can give rise to different protein isoforms which sometimes display different
structural and/or functional properties [Stryer (1995)]; see Figure 1. This is
known as alternative splicing. There are several classes of alternative splic-
ing events. For example, exon skipping occurs when an exon is selectively
“skipped” or excluded in the mature mRNA. See Supplementary Figure 1
for an illustration of some common splicing events.
In the late 80’s and early 90’s, only a few alternative splicing events were
known. Alternative splicing was considered a rare event, and its importance
misunderstood. Current estimates of the number of human genes that have
at least 2 splice variants range from 60 to 85% [reviewed in Cuperlovic-
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Culf et al. (2006)]. Different from other types of gene regulation, alternative
splicing does more than simply modulate the levels of expression of affected
genes. In extreme cases like the Dscam gene in Drosophila, the number of
potential splice variants is equivalent to almost double the total number
of genes present in the Drosophila genome [Celotto and Graveley (2001)].
Several different splicing events including exon skipping events, mutually
exclusive exons and alternative 5′ and 3′ splice sites form the repertoire of
alternative splicing. About 70–88% of differential splicing events affect the
coding region, and the numbers of known splicing events will increase thanks
to technologies such as alternative splicing arrays and RNA-Seq [Sultan et
al. (2008)].
Splicing arrays contain tens or hundreds of thousands of probes that are
complementary to exons or splice junctions (the fusion between exons) of
the different splice isoforms of many genes. These probes bind specifically to
segments within a transcript and quantify the concentrations of specific ex-
ons and splice junctions. Splicing arrays provide higher resolution measure-
ments across the length of the transcript compared to standard expression
arrays that bind to a smaller, selective portion of the transcript. See Figure
1 for the placement of splice junction probes. For a review of the different
classes of alternative splicing microarrays see Moore and Silver (2008). The
analysis of alternative splicing arrays is an area in need of improvement
due to difficulties in estimating the relative concentrations of isoforms with
or without a fully known sequence. Currently, there are several statistical
methods available, but none is satisfactory because of limitations in appli-
cation and inaccuracy [see Cuperlovic-Culf et al. (2006)]. The basic goal of
the methods is to estimate the proportions of splice variants within a tissue
and to compare these proportions between tissues. For example, we would
like to estimate the relative prevalence of two isoforms in one tissue (say,
a 1:2 ratio) and compare them to the relative prevalence in another tissue
(say, a 2:1 ratio). If these relative prevalences are different, then we have
an occurrence of differential splicing between the tissues. The analysis of
alternative splicing events is a more complicated task than quantifying the
overall level of expression of a gene as typically done by expression arrays.
In expression analyses that compare the overall expression of a given gene
in two tissues (e.g., cancer and normal), three scenarios are possible: higher
expression in cancer, higher expression in normal, and equal expression.
These measurements can be obtained, in principle, with one probe per gene.
In alternative splicing arrays, there is a set of probes for each alternative
splicing event; they normally cover splice junctions and/or the region that
is alternatively spliced. A substantial percentage of human genes have two
or more alternative splicing events that need to be evaluated individually.
The resultant isoforms are multivariate components of the gene’s expression.
Each of these isoforms itself may be up- (or down) regulated in a comparison
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between tissues. Further, if all of the isoforms are up- (or down) regulated,
then one may additionally ask whether they occur in the same proportion
in different tissues. Again, the comparisons of the relative proportions of
isoforms between tissues is one of the central issues in alternative splicing
analysis.
The increase in transcript information is the motivation for examining
alternative splicing in cancerous tissue, but the added statistical complexity
of the data requires novel and robust analytical methods. Srinivasan et al.
(2005) developed the Splicing Index statistic for exon arrays. This method
estimates the proportion of alternative isoforms by assuming a linear re-
lationship between mRNA concentration and probe intensity. The analysis
of splice variation (ANOSVA) proposed by Cline et al. (2005) is a similar
method that uses a parametric model. ANOSVA uses a two-way analysis of
variance model with an interaction where the first factor is the tissue type
level (tumor, normal, etc.) and the second factor is the probe (splice junction
1, splice junction 2, etc.). In ANOSVA, the interaction between treatment
effect and the probe effect corresponds to a differential splicing event (DSE).
However, like the Splicing Index, ANOSVA depends on the linearity of the
intensity response curve and may have a high false positive detection rate.
Shai et al. (2006) presented GenASAP as another analysis method, but
this potentially powerful tool has limited applicability. GenASAP uses a la-
tent variable Bayesian model and machine learning techniques to estimate
the percentage of each splice variant in a sample. Although GenASAP was
designed to distinguish between only two isoforms, many genes may have
multiple isoforms, and this limits the GenASAP method to a fraction of
genes that only have two isoforms or to those genes that are determined by
other methods to have only two prominent isoforms. Xing et al. (2008) have
created normalization and analysis methods for exon array data. While their
proposed normalization technique applies to splice junction arrays, the splice
junction array data will likely benefit from models specifically designed for
junctions. Splice junction arrays differ from exon arrays in that the probe
sequences correspond to the junctions between fused exons in the final tran-
script. The number of possible splice junctions exceeds the number of exons
because if the number of exons is E, the number of junctions is potentially(
E
2
)
, not counting partial exons, but there is a lack of knowledge about which
junctions actually occur in nature. Further, unlike exons, certain splice junc-
tions are incompatible within the same transcript based upon the topology
of splicing because splicing preserves the order of the exons. For example,
a transcript with a junction fusing exons 2 and 4 is incompatible with a
junction fusing exons 2 and 3 because exon 3 is excluded by junctions 2–4.
Our proposed method is designed to accommodate these features of junction
arrays.
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We present Rank Change Detection (RCD) as a method for identifying
differential splicing events (DSEs) based upon a Bayesian model comparing
the over or underrepresentation of two or more competing isoforms. RCD
has advantages over commonly used methods as it is robust to false positive
errors due to nonlinear trends in microarray measurements and it tests hy-
potheses of inherent biological interest. Gaidatzis et al. (2009) have recently
shown that these nonlinear effects in Affymetrix exon arrays are a source of
inaccuracy using current linear models, and we show that such nonlinearity
is found in two color splice junction arrays as well. RCD does not depend
on prior knowledge of splicing isoforms, yet it takes advantage of the inher-
ent structure of mutually exclusive junctions. This method may easily be
adapted to multiple platforms including other types of alternative splicing
microarrays or RNA-Seq data.
2. Experimental design and data structure. The objective is to iden-
tify splicing differences between normal and tumor tissues or cell lines. In
our experiment the normal cell line is the glial cell line known as FGG,
which is compared on each array to one of four glioblastoma tumor types.
This particular experimental design is called a reference design because the
normal sample is used as a comparator on each array [Kerr and Churchill
(2001)]. The two-color microarrays have probes that bind to splice junctions
simultaneously within two samples that are labeled to fluoresce at green
and red wavelengths using Cyanine-5 (Cy5) dye and Cyanine-3 (Cy3) dye,
respectively. The intensity of fluorescence quantifies the amount of RNA ex-
pression. The dye orientation is balanced so that for each tumor type, the
normal and tumor samples are labeled with Cy3 and Cy5, respectively, or
Cy5 and Cy3, respectively, in an equal number of replicates. This is called
a dye-swap design, and the experimental layout is shown in Supplemental
Table 1. The log-probe intensity data for a given gene are denoted as ytjrds
where the indices t, j, r, d and s represent tissue, junction, replicate, dye
and spot respectively. Note that t refers to the type of cells sampled whether
from a tissue or a cell line or culture, but we will refer to t as tissue without
loss of generality. We found that there was little to no dye bias so we drop
this distinction (index d) for convenience. The spot or probe effect induces
correlation between the red and the green channels that are measured for
each probe. The junction j is defined by the location (in DNA base pairs or
bp) from the transcription start site (or another reference site) of the 5′ and
the 3′ sites (j5 and j3) that define the interval [j5, j3] of the excised seg-
ment of the transcript. Two junctions j and j′ are mutually incompatible if
[j5, j3]∩ [j
′
5, j
′
3] 6=∅. The nonempty intersection indicates that one junction
excises a component of the other, thus making mutually exclusive within
the same transcript; see Figure 1. The set of all junctions incompatible with
junction j is denoted as Oj . This implies that the junction j is in the set
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of incompatible junctions Oj (j ∈ Oj). There are possibly more incompat-
ible junctions in the set Oj if one had knowledge of biologically plausible
transcripts and their corresponding junctions. Our method of defining in-
compatible sets has the advantage that it does not require that the full
transcript sequences are known. The specification of these sets is critical
because this defines the set of junctions whose proportions are being com-
pared. One typically compares the relative prevalence ptj′ of the junctions
j′ ∈Oj for each tissue t1, t2 where
∑
j′∈Oj
ptj′ = 1, and the null hypothesis
for a differential splicing event (DSE) is pt1j′ = pt2j′ for j
′ ∈Oj .
3. Rank change detection method. The model of Cline et al. (2005) is
an ANOVA model described by E[ytjr] = µtj = µ0 + αt + βj + γt×j and α,
β and γ are the effects of tissue, junction and the interaction between the
tissue and junction. The rejection of the test of γt×j = 0 implies a differential
splicing event. That is, the γt×j represents the relative increase or decrease
in the junction j prevalence in tissue t. However, the model becomes invalid
in the presence of nonlinearity. For example, if there is not a DSE and
there are two incompatible junctions (A and B), then we denote the mean
intensities of the probes by µtj, say, µNA, µNB , µCA and µCB where N
and C are the normal and cancer tissue indices. According to the ANOSVA
model, µtj = µ0 + αt + βj + γt×j , so that if γt×j = 0, then µCA − µNA =
µCB − µNB . Equivalently, if there is no DSE, then the difference between
junction probe mean intensities should be equal. Substantial nonlinearity
results in an extremely high false positive rate due to the phenomenon in
Figure 2A. For example, we examine our data for the VIM gene shown in
Figure 3. On the vertical axis is the estimate of the mean junction differences
(µˆCj − µˆNj), and on the horizontal axis is the estimate of the mean junction
intensity 1
2
(µˆCj + µˆNj). Clearly, the difference µˆCj − µˆNj is not equal for all
junctions with the high and low intensity junctions having differences closer
to 0. This dependence on intensity is consistent with nonlinear response as
in Figure 2A. The ANOSVA test for γt×j = 0 results in a p-value < 10
−19,
which would likely yield a false positive result because nonlinear response
to differential expression is confounded with the hypotheses about junction
by tissue interactions.
We propose a model for rank change that tests the hypothesis that a
junction has the same rank in relative proportion in one tissue compared
to another, as measured by probe intensity. We define the rank of ptj as
R(ptj) =
∑
j′∈Oj
I[ptj′ ≤ ptj ] where I[·] is the indicator function. Instead of
the null hypothesis that proportions themselves are equal, pt1j′ = pt2j′ for
j′ ∈Oj , we will test that the ranks of the ptj are equal, R(pt1j′) =R(pt2j′)
for j′ ∈ Oj , by making the reasonable assumption that the ranks in mean
junctions intensities µtj approximate the ranks of the junction proportions
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Fig. 2. (A) Example of sigmoidal response of microarray Intensity: Two incompatible
isoforms A and B present in 1:2 a ratio at high (++) and low (+) levels of overall gene
expression. Notice that the intensity difference between the two isoforms is narrowed con-
siderably in lower concentration despite the constant concentration ratio of 2:1. Models
assuming linearity could falsely estimate that the ratio of isoforms had narrowed from 2:1
to closer to 1:1. (B) Rank Changes of isoform intensity are invariant under monotonic
transformation. There are two incompatible isoforms A and B present in normal (N),
cancer (C). Isoform A is more prevalent in cancer, while isoform B is more prevalent in
normal. The proposed method identifies such changes in prevalence rankings of isoforms.
The mean intensities are shown on the vertical axis as µtj .
ptj . A shift in rank represents a decrease or increase in the prevalence of
the isoform as shown in Figure 2B. The justification for assessing ranks is
that ranks are preserved under monotonic transformation due to nonlinear
response, whereas differences in intensity (i.e., γC×j = µˆCj − µˆNj) are not.
We propose the following random effects implementation of the ANOSVA
model for two color arrays:
ytjrs = µtj + νtjrs + εtjrs,(3.1)
where the µtj are the means of the jth junction in tth tissue and εtjr is
an independent Gaussian noise error term. The term νtjrs is a Gaussian
random effect corresponding to a probe on an array, and this random effect
is two-dimensional corresponding to the red and green dyes. The main idea
of detecting rank change comes from the following example. If there is not a
DSE and there are only two junctions (A and B), then the ranks of the mean
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Fig. 3. Difference vs Average plot for splice junctions of theVIM gene. Each point is
the average value of a specific junction. The horizontal axis is the estimate of the mean
junction intensity 1
2
(µˆCj + µˆNj), and the vertical axis is the estimate of the mean junction
differences (µˆCj − µˆNj). Note the substantial nonlinear effect apparent in the parabolic
trend. This invalidates algorithms based upon linearity such as ANSOVA likely resulting
in false positives.
intensities (µtj′ , j
′ ∈Oj) are preserved. In other words, µNA < µNB implies
that µCA < µCB where N and C are the normal and cancer tissue indices.
This is equivalent to saying junction B is more prevalent than junction A
in both tissues, assuming that intensities of the two junction probes roughly
reflect their relative concentrations. If the ranks of the junction prevalences
change as in Figure 2, then there is a DSE. For an arbitrary number of
isoforms, no DSE implies that the ranks of the µtj are preserved across
tissues. We do not directly observe the ranks of the latent means µtj as
there is variability in measurement, but we can estimate the latent ranks of
the means from the posterior distribution. Let the rank of the mean intensity
µtj of junction j within a tissue t be defined as R(µtj) =
∑
j′∈Oj
I[µtj′ ≤ µtj ].
Our null hypothesis for a DSE between tissues t1 and t2 would be that
R(µt1j) =R(µt2j).
That is, the rank of the average intensity of junction j relative to other
incompatible junctions j′ ∈ Oj is preserved across tissues. Since there are
40,000 models corresponding to each junction on the chip, we will estimate
the posterior distributions using approximations to accelerate model fitting.
We can approximate the posterior distributions of µtj by the maximum
likelihood theory point and variance estimates (µˆtj and Σˆµ). We estimate
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and compare the posterior distributions of R(µt1j) and R(µt2j) with Monte-
Carlo integration of the posterior distribution p([µt1, . . . , µtJ ]|Data) where
J = size of Oj . The posterior distributions of R(µtj) are approximated by
computing
∑
j′∈Oj
I[µtj′ ≤ µtj ] from samples of [µt1, . . . , µtJ ] drawn from the
multivariate Gaussian with mean [µˆt1, . . . , µˆtJ ] and variance Σˆµ. We define
the posterior probability of a rank increasing (U ) or decreasing (D) DSE
as Pr(R(µt1j) > R(µt2j)) = Dt1t2j and Pr(R(µt1j) < R(µt2j)) = Ut1t2j and
estimate these with the Monte-Carlo sample proportions satisfying these
events. If max(Ut1t2j ,Dt1t2j)>κ where κ is a cutoff (say 0.9), then we declare
junction j differentially spliced between tissues t1 and t2.
We use the term latent ranks because it is important to distinguish the
proposed method of ranking the posterior means from the typical use of rank
statistics computed directly from the observed values. For example, Tan et
al. (2005) use rank reversals for microarray classification in a method called
Top Scoring Pairs, and they compute the ranks of the raw microarray inten-
sities and characterize the variability of the ranks based upon the observed
frequencies of orderings. Given that microarray experiments have substan-
tial measurement error as well as potentially large effect sizes, we need to
maximize the accuracy and carefully quantify variability in rank estimates.
When the sample sizes are small as is often the case in differential splicing
experiments, using the ranks of the posterior means may have advantages
over using the frequencies of the orderings. Figure 4 shows two scenarios of
how the ranks of posterior means lead to different results than using the
observed ranks. The axes are the log expression levels of 2 junctions, and
the 95% highest posterior density (HPD) regions of the posterior means are
outlined. Case 1 demonstrates that one may estimate the posterior rank of
the mean of Junction 2 to be higher than Junction 1 with 95% confidence
given only two observations if Junction 2 is much greater than 1 relative
to the error variance. However, if one considered relative frequencies of the
ranks of two randomly ordered pairs, then the pattern would occur 25% of
the time. In case 2, there are four observations, and 3 out of 4 show Junc-
tion 2 having higher rank than 1. Because the posterior density has a small
variance, the posterior mean of Junction 2 has a 95% probability of being
higher than Junction 1 even though 25% of the observations show this not
to be the case. RCD maintains high power in low sample size compared to
other ranking methods because it does not use the raw ranks as it takes
into account the magnitude of differences relative to the variances and not
just the observed ordering. Therefore, using the posterior ranks of means
gives different results from using the raw ranks, and this is appropriate for
detecting associations of relative junction prevalence with biological condi-
tion in experiments with small sample sizes. However, using the frequency of
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Fig. 4. A hypothetical experiment demonstrating that the posterior ranks of the means
provide more evidence compared to the ranks of the raw observations. The 95% HPDs for
the posterior means are drawn as ellipses. In both cases, the prevalence of Junction 2 is
greater than Junction 1. In case 1, there are only 2 observations, but the posterior distribu-
tion strongly favors higher rank for Junction 1. However, this frequency of observed ranks
would randomly occur 25% of the time. In case 2, there is > 95% posterior probability that
Junction 2 has higher mean than Junction 1, even though the observed relative frequency
that Junction 2 is greater than Junction 1 is only 75%. The accuracy of the evidence from
the posterior depends upon parametric assumptions.
observed ranks as in Tan et al. (2005) is more appropriate for discriminat-
ing biological states for the purposes of classification with relatively large
sample sizes.
The accuracy of the posterior relies upon distributional assumptions and
the reasonableness of the prior. The distributional assumption of the nor-
mality of residuals is an accepted approximation for microarrays [Cline et al.
(2005); Kerr and Churchill (2001)], and we found this is reasonable for our
data. We chose a noninformative prior based upon the MLE approximation,
but one may tune the influence of the prior by altering the threshold κ to
be more or less conservative. It is conceivable to avoid the use of priors by
constructing a frequentist test for latent rank, but this could be relatively
cumbersome given the difficulty of maximum likelihood estimation on the
discrete rank space.
The model identifies the event that the prevalence of one junction sur-
passes or becomes less than another junction in different tissues. This model
detects a shift in intensity ratios between junctions such as 1:2 changing to
2:1, but the model does not detect changes in ratios such as 3:5 changes to
4:5. This way, the rank change model tests qualitative changes in preva-
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lence such as when isoforms go from dominant (highest rank) to nondom-
inant (lesser rank) rather than detecting merely quantitative changes in
junction prevalence. We suggest that such qualitative changes have more
biological impact and are worth specific detection algorithms. The RCD
method is implemented in the R programming language, and is available at
http://sites.google.com/site/gbiostats/.
4. Simulation study. We performed a simulation to directly compare the
performance of the RCD method to ANOSVA in terms of the false positive
rate. We anticipated that ANOSVA would perform well in the absence of
nonlinearity, but in the presence of nonlinearity, it would have an unaccept-
ably high false positive rate. We simulated data under 4 different scenar-
ios: 2 incompatible isoforms and linear response, 2 isoforms and nonlinear
response, 3 incompatible isoforms and linear response, and 3 incompatible
isoforms and nonlinear response. We used the previously discussed ANOSVA
model for simulation E[ytjr] = µtj = αt + βj + γt×j . In each case, we had 2
tissue types and 12 two color arrays in a balanced, dye-swap design. The tu-
mor tissue differential expression effect (αt) was simulated to consist of a log
fold-change using a Gaussian distribution of mean 0, standard deviation 1,
and the normal tissue level was drawn from the empirical distributions of
the means of the normal cells in our data set. The relative prevalences of
the incompatible junctions (exp(βj)) were simulated from different Dirichlet
distributions with parameters (1,1) for 2 junctions or (1,1,1) for 3 junctions.
Because we are estimating the false positive rates, the simulation examines
scenarios such that there are no differential splicing events (γt×j = 0). The
random error was an empirical distribution of the residuals of the reference
channel with mean 0 and standard deviation of 0.22, and no spot specific
effects were simulated, as these effects were observed to be relatively small
in the data. The nonlinear effect was simulated by transforming E[ytjr] with
a linear transformation of a logistic function that approximates the dynamic
range of the array P (x) =w/(1 + exp(−(x− µ∗)/σ∗)) + δmin where w = 9.2
is the width of the observed dynamic range on the log scale; δmin = 6.3 is
the minimum of the dynamic range; µ∗ = 10.9 is the midpoint between the
minimum and maximum of the dynamic range; and σ∗ is selected so that
P (x) has slope = 1 when x= µ∗. The estimate of the false positive rate was
based upon a p-value cutoff of 0.05 for the ANOSVA model (γt×j = 0), and
a cutoff of posterior probability of unequal ranks of κ = 0.9 for the rank
change model. We obtained the false positive rates for 1000 simulations as
shown in Table 1.
The false positive rate of ANOSVA is close to the nominal 0.05 value
under the linear scenarios, albeit somewhat inflated due to slight violations
of parametric assumptions, but ANOSVA has a substantially inflated false
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Table 1
False positve rate for RCD model and conventional ANOSVA model
Model
Scenario ANOSVA RCD
2 junction linear 0.063 0.000
2 junction nonlinear 0.165 0.008
3 junction linear 0.057 0.001
3 junction nonlinear 0.194 0.010
positive rate of 3–4 times higher than the nominal value under the nonlin-
ear scenarios. In contrast, the cutoff of 0.9 probability of differential splicing
has a tolerably low false positive rate. The simulation suggests that the
nominal p-values obtained for differential splicing detection could lead to an
unacceptably high rate of false positive calls in the presence of nonlinearity.
In general, we found that estimation of larger numbers of mutually incom-
patible junctions resulted in more false positives for both models. For this
reason, we recommend that the maximum size of Oj considered be less than
10 or to adjust the posterior probability cutoff for larger Oj .
We also performed a power analysis to demonstrate that the power loss
due to the use of ranks is not too great compared to ANOSVA. We con-
sidered power in both the linear and the nonlinear cases for two opposing
junctions, and we simulated random error and tissue effects based upon em-
pirical values as previously described. The interaction between tissue and
junction was selected to be rank reversals of two opposing junctions such
that a ratio of prevalence of x :y in one tissue is reversed to y :x in the other
tissue. Without loss of generality, if x= 1, then the effect size of the inter-
action log scale would be 2 log2(y). We varied the effect size from log2(1) to
2 log2(8) for the nonlinear case and from log2(1) to 2 log2(1.5) in the linear
case, and varied the sample size from n= 4 to 12. When the interaction ef-
fect size is 0 = log2(1), the junction effect is equal in both tissues and chosen
at random from the range of log2(1.5) to log2(8) for the nonlinear case and
from log2(1.05) to log2(1.5) in the linear case. The results of 1000 simula-
tions per scenario are shown in Supplementary Figure 2. In the nonlinear
case, ANOSVA has Type I error rate of 0.212 and 0.308 for sample sizes of 4
and 12, respectively, compared to 0.004 and 0.000 for the RCD model. The
power comparison in the nonlinear case favors ANOSVA by approximately
10%, although this is balanced by an increase in the Type I error of more
than 10-fold. In the linear scenario, the relative power of ANOSVA vs. RCD
is similar to the nonlinear scenario while the sensitivity of both methods to
detect DSE is increased. In the power comparison, there are two issues that
need to be emphasized. First, the RCD model detects only cases when there
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is a qualitative difference in rank so that quantitative changes in prevalence
such as 1:2 to 1:3 cannot be reliably detected. Second, the posterior proba-
bilities given by RCD and the p-values of ANOSVA have different meanings,
and this complicates direct comparisons.
5. Application to glioblastoma data. We studied one normal brain cell
line (FGG) and four glioma lines (U87MG, U118MG, T98G and A172). The
arrays used in our analysis were designed by JIVAN Biologicals (San Fran-
cisco, CA) and manufactured by Agilent (Santa Clara, CA). They contain
2145 genes identified to be related to cancer by literature search. There were
38,425 splice junctions or potential alternative splicing events represented
on the arrays as probes of length 35–40 bp. The probe sequences were based
upon build hg17 and can be downloaded with the raw and normalized data
from the Gene Expression Omnibus (GPL10127 and GSE20723). 200 ng of
each RNA sample were labeled with Cy3/Cy5 dye using Agilent Low RNA
Input Linear Amplification kit as per manufacturers protocols. After am-
plification, 750 ng each of Cy3 and Cy5 labeled RNA were combined and
hybridized to microarrays. A two color microarray based gene expression
analysis protocol (Agilent) was used. The normal FGG line was used as a
reference for all arrays in a dye-swap design with the 4 glioma lines being la-
beled Cy3 and Cy5 two times each for a total of 16 arrays. See Supplemental
Table 1 for a layout of the experimental design. Microarrays were scanned
using the Agilent Microarray Scanner G2565AA and extracted using Agilent
feature Extraction Software version 9.1. Array data preprocessing and nor-
malization were performed using the SpliceFold software JIVAN Biologicals
(San Francisco, CA).
The size of the sets of incompatible junctions considered ranged from
2 to 10. The percentages of sets with 2, 3, 4 and 5 junctions were 31%,
19%, 11% and 8%, respectively. We examined the incompatible sets cor-
responding to each junction. The RCD model fit indicates that hundreds
of junctions have posterior probability for rank change of > 0.9; see Table
2A. Note that some events counted may be interrelated, as some sets of in-
compatible junctions have nonnull intersections. A full list of the significant
genes and junctions are downloadable from the url. We also compared the
results with the ANOSVA method shown in Table 2B. Here, a junction is
called differentially spliced if the false discovery rate (FDR) estimated by
the qvalue is less than 0.1 [Storey and Tibshirani (2003)]. The qvalue crite-
rion is inherently more liberal than the posterior probability criterion, but
this difference is modest. Table 2C demonstrates the overlapping significant
junctions satisfying both criteria for the RCD and the ANOSVA models.
Note that most of the junctions identified as significant according to the
rank change model are declared significant according to ANOSVA model.
The number of junctions identified by ANOSVA is much higher, although,
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Table 2
Number of alternative splicing events between cell types for RCD and ANOSVA models
Cell type FGG A172 T98G U118
A. RCD A172 364
T98G 344 365
U118 389 348 399
U87 333 334 311 264
B. ANOSVA A172 6058
T98G 7610 11,106
U118 7771 8695 8890
U87 6590 8319 7546 5048
C. RCD & ANOSVA A172 267
T98G 286 346
U118 351 316 367
U87 301 282 274 213
we argue, that the results are heavily confounded with the substantial dif-
ferential expression within the experiment. To demonstrate the confounding
between differential expression and the differential splicing events estimated
by ANOSVA, we tested the hypothesis that the junctions that were differ-
entially expressed were more likely to be declared a DSE. By differentially
expressed, we mean that the average expression in one cell line is higher
than the other for a given set of junctions. Figure 5 shows evidence for dif-
ferential splicing events estimated by ANOSVA and the RCD model and
their relationship to the estimated differential expression. The evidence for
a DSE for the ANOSVA model is quantified by the local false discovery
rate (lFDR) [Pounds and Cheng (2006)]. In Figure 5A, the ANOSVA model
estimate of local false discovery rate for differential splicing (Posterior Prob-
ability of No DSE) has a strong dependency on the log fold change estimate
for differential expression. This indicates the higher fold change estimates
for differential expression imply higher posterior probability of differential
splicing. This is consistent with the idea that the nonlinear effects within the
microarray confound the hypotheses about splicing and differential expres-
sion, and that the estimates of differential splicing are biased and substan-
tially overestimated. In Figure 5B, the RCD model estimate for differential
splicing probability has little dependency on overall changes in expression.
This is consistent with the robustness of the rank change model to bias due
to change in expression level.
We also examined whether the genes with splicing events reported in
the literature for glioblastoma had greater posterior probability for splicing
under the ANOSVA and the RCD models. Cheung et al. (2008) reported
such genes from multiple studies, including 8 that were assessed by our
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Fig. 5. Splicing Probability vs differential expression Log Fold Change. (A) The
ANOSVA model estimate of local false discovery rate for differential splicing (− log10 Pos-
terior Probability of No DSE) has a strong dependency on differential expression fold
change (| logFold Change|). A spline curve is shown in red, and the mean − log10 lFDR
of differential splicing is in blue. This indicates that the higher fold change for differential
expression implies higher probability of differential splicing. The nonlinear effects within
the microarray confound the hypotheses about splicing and differential expression. (B) The
RCD model estimate for differential splicing probability has little dependency on overall
changes in expression. A spline curve is shown in red, and the mean − log10 posterior
probability of no differential splicing is in blue.
arrays: CALD1, CASP2, FGFR1, NF1, RAB3A, ST18, TNC and TPD52L2.
For all comparisons between cell types, we computed the enrichment ratio
which we define as the proportion of significant DSEs in the previously
reported genes relative to proportion of significant DSEs in all other genes
at various cutoffs. The cutoffs we used for the RCD model were posterior
probabilities for rank change greater than 90%, 99%, 99.9% and 99.99%, and
the cutoffs for ANOSVA were lFDR values of less than 10−1,−2,−3,...,−15. The
results are in Supplemental Tables 2 and 3. The enrichment ratio peaked at
3.17 for ANOSVA when the cutoff was 10−14, giving 36 significant DSEs in
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the known genes. The enrichment ratio plateaued at 13 for RCD when the
cutoff was 99.99%, giving 18 significant DSEs in the same genes. However, at
the corresponding cutoffs in RCD and ANOSVA resulting in 36 significant
DSEs in the known genes, the RCD enrichment ratio was 6.7 compared
to 3.17 for ANOSVA. This implies that the RCD method found that the
known genes were substantially more enriched for DSEs than the ANOSVA
method for equally conservative cutoffs. We repeated the above enrichment
score estimation with randomly selected sets of 8 genes, and found that
< 1% of these sets give a DSE enrichment score greater than the known
genes.
6. Discussion. We presented a model for the detection of differential
splicing events in the presence of substantial nonlinear effects of the mi-
croarray intensity response. This model is robust to the violations of the
assumption of linearity and is designed to detect features of alternative splic-
ing that are invariant under monotonic transformation. One difficulty with
the model is that differential splicing may occur without exhibiting the in-
variant feature of rank change. Although these features are likely present
in the most dramatic and biologically important differential splicing events,
the proposed model may have lower power to detect more subtle shifts in the
proportions of isoforms expressed in different tissues. We choose to trade sen-
sitivity for specificity in the current setting as the false positive rate (though
not knowable) is potentially quite high for other methods. This method may
be used with either one- or two-color splice junction array technology and
can be applied to data with or without nonlinear effects to identify quali-
tative changes in junction prevalence. It may be argued that filtering out
either very low or very high measurements from downstream analysis would
reduce the degree of nonlinearity in the data. However, the selection of a
cutoff would be difficult and error prone. Furthermore, very high and very
low intensities can be informative so that the removal of meaningful mea-
surements degrades the signal in the data.
There are several opportunities to extend the proposed model. We es-
timated the posterior distribution based upon the MLE, and this has the
effect of selecting noninformative priors. Noninformative priors imply that
there is an equal probability of there being an alternative splicing event
or not, but the accuracy of the method could be improved if one utilized
data on the prior probability of particular alternative splicing events. The
hypothesis of rank change can be extended to any model for which there
are posterior distributions of parameters related to the ranks of relative
isoform prevalence. First, we may explicitly model the sigmoidal response
of the microarray intensity with some appropriate parametric link function
g(·) so that we have g(E[ytjr]) = µ0 +αt + βj + γt×j . This would likely add
to the computational challenge of fitting the model, but it would improve
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sensitivity to detect DSEs. If we next consider g(·) as a link function in a
log-linear count model, we may model splice junction counts from RNA-seq
data instead of microarray intensity. Second, we had assumed that the error
terms εtjr were independent of one another, although it is likely that the
incompatible isoforms have errors that are negatively correlated, and these
correlations of the residuals can be modeled using a compound symmet-
ric structure. Third, we may extend the model to include knowledge of the
transcripts by adding a latent variable for each known isoform such that
ytjr =
∑
h
βjzhtδhj + νtjr + εtjr,(6.1)
where βj is the effect of junction j, zht is the latent variable proportional
to the amount of isoform h within the tissue t, and δhj is the indicator
variable for whether or not junction t is within junction h. This extension
could incorporate exon probes as well. The latent variable zht would be
an indication of the prevalence of the isoform, and estimating the ranks and
differences in zht would help to identify differential splicing events by pooling
information across junctions and exons within a complete isoform.
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